March 19, 2019 Bio/Pharma/CRO Chromatography Environ, Ag./Food & Bev Lab Top-10 Mass Spectrometry Molecular Spectroscopy Product Launch

Thermo Fisher Scientific Innovations at Pittcon 2019 Enable Workflows Across Life Sciences, Applied and Industrial Markets

PHILADELPHIA, March 19, 2019 /PRNewswire/ — Pittcon 2019 — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is introducing innovative products, software and services for customers working in biopharma, food safety, environmental quality and industrial applications during the 2019 Pittcon Conference and Exhibition. The company will showcase analytical workflows that enable fast, precise analyses... Read more

March 18, 2019 Bio/Pharma/CRO

Thermo Fisher Scientific to Invest $150 Million to Expand Pharma Services Capabilities

Expansion projects will increase capacity to meet growing customer demand for biologics WALTHAM, Mass., March 18, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is investing $150 million in its Pharma Services business to provide additional capacity for sterile liquid and lyophilized product development... Read more

March 18, 2019 Bio/Pharma/CRO Lab Top-10 PR/Corporate

Thermo Fisher Scientific to Invest $150 Million to Expand Pharma Services Capabilities

Thermo Fisher Scientific to Invest $150 Million to Expand Pharma Services Capabilities Expansion projects will increase capacity to meet growing customer demand for biologics WALTHAM, Mass., March 18, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is investing $150 million in its Pharma Services... Read more

March 18, 2019 Bio/Pharma/CRO Clinical Research/Diagn. Environ, Ag./Food & Bev Informatics & Software Lab Top-10 Mass Spectrometry Molecular Spectroscopy Product Launch

Bruker Highlights New Systems and Applied Market Solutions at Pittcon

PHILADELPHIA, March 18, 2019 /PRNewswire/ — At Pittcon 2019, Bruker (Nasdaq: BRKR) this week highlights new and innovative analytical systems and high-value applied market solutions for food analysis, pharma applications, materials science research and quality control, clinical and preclinical research, and advances in scientific software solutions. Frank H. Laukien, Ph.D., Bruker’s President and CEO, commented:  “Our... Read more

March 14, 2019 Bio/Pharma/CRO Clinical Research/Diagn. Product Launch

Lonza Expands Mycoplasma Detection Portfolio with New Luminometer Designed to Accelerate and Simplify Testing

Walkersville, MD (USA) / Basel, Switzerland, 14 March 2019 – Lonza has further strengthened its extensive mycoplasma detection portfolio with the addition of the Lucetta™ 2 Luminometer, a single-tube system designed to simplify and accelerate mycoplasma detection in cell cultures. Pharmaceutical, biotechnology and academic researchers can now rely on this compact, portable and easy-to-use instrument to... Read more

March 14, 2019 Acad, Gov/Utilities Bio/Pharma/CRO PR/Corporate

BD Receives U.S. FDA Approval for First Venous Stent to Treat Iliofemoral Venous Occlusive Disease

FRANKLIN LAKES, N.J., March 14, 2019 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration has granted premarket approval for the Venovo™ venous stent, the first stent indicated to treat iliofemoral venous occlusive disease, which is obstructed or narrowed blood flow specific to... Read more

March 7, 2019 Bio/Pharma/CRO Life Science Tools Product Launch

Nuvec®: A breakthrough technology for mRNA / pDNA delivery for vaccines and cancer treatments

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company, is developing Nuvec® – a unique non-viral adjuvant delivery system for vaccines and cancer treatments. This silica nanoparticle has the potential to help commercialize cancer immunotherapy drugs and improve the effectiveness of viral vaccines. Nuvec® silica nanoparticles have a unique irregular (spikey) surface structure, coupled with... Read more

February 25, 2019 Bio/Pharma/CRO Lab Top-10 Product Launch

Thermo Fisher Scientific Launches New Dosimetry Monitoring Service

Medical and dental facilities, nuclear power plants and other sites can now simplify their radiation safety program by accessing dosimetry technology and services from single provider TEWKSBURY, Mass., Feb. 25, 2019 /PRNewswire/ — A new dosimetry monitoring service from Thermo Fisher Scientific enables medical and imaging facilities, dental offices, veterinary clinics, nuclear power plants, laboratories and... Read more

February 21, 2019 Bio/Pharma/CRO Cell Analysis Tools Product Launch

Releasable antibodies for label-free cells

Multicolor flow cytometry-based cell sorting is the method of choice for isolating specific cell subsets. However, downstream applications using isolated cells are often limited since fluorescence channels and epitopes are blocked by the antibody-fluorochrome conjugates utilized for the flow sorting process. Miltenyi Biotec’s REAlease® Releasable Antibodies with the REAlease Fluorochrome Technology can be removed from... Read more

February 6, 2019 Bio/Pharma/CRO Lab Top-10 PR/Corporate

Merck KGaA, Darmstadt, Germany to Expand US Biopharmaceutical R&D Facility to Advance Innovative Clinical Pipeline

BILLERICA, Mass., February 6, 2019 — Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, today announced a $70 million investment to expand its state of the art research and development (R&D) facility in Billerica, Massachusetts. The new building will span 145,000 square feet, offering new laboratory... Read more